Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5) Antibody
312€ (100 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Name
Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx104213
Tested Applications
IHC
Description
Polyclonal Antibody to Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5).
Documentos del producto
Instrucciones
Data sheet
Especificaciones del producto
| Category | Primary Antibodies |
| Immunogen Target | Target: Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5) Immunogen: UCHL5 (Cys27-Pro246) |
| Host | Rabbit |
| Reactivity | Cow |
| Recommended Dilution | WB (Predicted): 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC (Predicted): 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Purification | Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography. |
| Size 1 | 100 µl |
| Size 2 | 200 µl |
| Size 3 | 1 ml |
| Form | Liquid |
| Tested Applications | IHC |
| Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
| Availability | Shipped within 5-7 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Alias | UCH37,CGI-70,INO80R,UCH-L5,Ubiquitin carboxyl-terminal hydrolase isozyme L5,Ubiquitin thioesterase L5 |
| Background | Antibody anti-UCHL5 |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Background
UCHL5, also known as UCH37, is a deubiquitinating enzyme (DUB) that plays a key role in the ubiquitin-proteasome system by removing ubiquitin chains from proteasomal substrates, thereby regulating protein turnover and degradation. UCHL5 interacts with the 19S regulatory particle of the 26S proteasome, facilitating the recycling of ubiquitin to maintain cellular proteostasis. It is involved in DNA repair, cell cycle progression, and stress responses, making it crucial for cellular homeostasis. UCHL5 has also been implicated in tumorigenesis, where its overexpression promotes cell survival, proliferation, and chemoresistance by preventing the degradation of oncogenic proteins. Inhibitors of UCHL5 have shown potential as anti-cancer agents by enhancing proteasomal degradation of key regulatory proteins. Knockdown studies reveal its role in impaired cell growth, defective DNA repair, and increased apoptosis, highlighting UCHL5's importance in protein homeostasis, cellular stability, and cancer progression.
Productos relacionados
Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5) Antibody
UCHL5 Antibody is a Rabbit Polyclonal Antibody against UCHL5.…
Ver producto
Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5) Antibody
Protease that specifically cleaves 'Lys-48'-linked polyubiquitin chains. Deubiquitinating enzyme associated with the 19S…
Ver producto
Ubiquitin C-Terminal Hydrolase UCH37 (UCH37) Antibody
Covalent attachment of the C-terminus of ubiquitin to cellular proteins plays a role in a variety of cellular processes.…
Ver producto